Skip to main content
. 2013 Nov;20(11):1743–1751. doi: 10.1128/CVI.00466-13

Fig 3.

Fig 3

Alleviation of CVB3-induced myocarditis by pHMGB1 coimmunization. (A) One representative heart section is shown for 5 mice per group (magnification, ×100). (B) Myocarditis was assessed as the percentage of the heart section with inflammation, compared with the overall size of the heart section, with the aid of a microscope eyepiece grid. Each group contained 5 mice. ∗, P < 0.05. (C) Survival rates of mice were observed until day 28 following challenge with a lethal dose of CVB3 (5 times the LD50). Each group contained 10 mice. Experiments were repeated three times with similar results. All of the experimental data were pooled and are presented together. ∗, P < 0.05; ∗∗∗, P < 0.001, versus the mock-immunized group.